Time course of circulating acute phase proteins and cytokines in septic patients

Amyloid

Volumn 4, Issue 1, 1997, Pages 33-39

  Fratelli, Maddalena ^a   Zinetti, Mirella ^a   Fantuzzi, Giamila ^a,b   Spina, Chiara ^c,d   Napoletano, Giulio ^c   Donatiello, Giuseppe ^c   Ravagnan, Ruggero ^c   Sipe, Jean D ^e   Casey, Clare A ^d   Ghezzi, Pietro ^a  

^a MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

^b TUFTS MEDICAL CENTER   (United States)

^c UNIVERSITY OF MILAN   (Italy)

^d IRCCS ISTITUTO ORTOPEDICO GALEAZZI   (Italy)

^e BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

C reactive protein; Interleukin 6; Sepsis; Serum amyloid A; Tumor necrosis factor

Indexed keywords

EID: 0009721974     PISSN: 13506129     EISSN: None     Source Type: Journal    
DOI: 10.3109/13506129708995266     Document Type: Article

References (26)

1. Latini R, Blanchi M, Correale E, Dinarello CA, Fantuzzi G, Fresco C, Maggioni A, Mengozzi M, Romano S, Shapiro L, Sironi M, Tognoni G, Turato R and Ghezzi P (1994). Cytokines in acute myocardial infarction: selective increase in circulating tumor necrosis factor, its soluble receptor, and interleukin-1 receptor antagonist. J Cardiovasc Pharmacol 23:1-6
2. Rusconi F, Parizzi F, Garlaschi L, Assael BM, Sironi M, Ghezzi P, Mantovani A and The Collaborative Study on Meningitis (1991). Interleukin 6 activity in infants and children with bacterial meningitis. Pediatr Infect Dis J 10:117-121
3. Tracey KJ, Fong Y, Hesse DG, Manogue KR, Lee AT, Kuo GC, Lowry SF and Cerami A (1987). Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature 330:662-664
4. de Groote MA, Martin MA, Densen P, Pfaller MA and Wenzel RP (1996). Plasma tumor necrosis factor in patients with presumed sepsis. JAMA 262:249-251
5. Calandra T, Baumgartner J-D, Grau GE, Wu M-M, Lambert P-H, Schellekens J, Verhoef J, Glauser MP and S-DJIS Group (1990). Prognostic value of tumor necrosis factor/cachectin, interleukin-1, interferon-α, and interferon-γ in the serum of patients with septic shock. J Infect Dis 161:982-987
6. Debets JM, Kampmeijer R, Van Der Linden MPMH, Buurman WA and Van Der Linden CJ (1989). Plasma tumor necrosis factor and mortality in critically ill septic patients. Crit Care Med 17:489-494
7. Marano MA, Fong Y, Moldawer LL, Wei H, Calvano SE, Tracey KJ, Barie PS, Manogue K, Cerami A, Shires GT and Lowry SF (1990). Serum cachectin/tumor necrosis factor in critically ill patients with burns correlates with infection and mortality. Surg Gynecol Obstetr 170:32-38
8. Mòzes T, Ben-Efraim S, Tak CJAM, Heiligers JPC, Saxena PR and Bonta IL (1991). Serum levels of tumor necrosis factor determine the fatal or non-fatal course of endotoxic shock. Immunol Lett 27:157-162
9. Pinsky MR, Vincent J-L, Deviere J, Alegre M, Kahn RJ and Dupont E (1993). Serum cytokine levels in human septic shock. Relation to multiple-system organ failure and mortality. Chest 103:565-575
10. Munoz C, Carlet J, Fitting C, Misset B, Blériot JP and Cavaillon JM (1991). Dissociation between plasma and monocyte-associated cytokines during sepsis. Eur J Immunol 88:1747-1754
11. Waage A, Brandtzaeg P, Halstensen A, Kierulf P and Espevik T (1996). The complex pattern of cytokines in serum from patients with meningococcal septic shock. J Exp Med 169:333-338
12. Hack CE, De Groot ER, Felt-Bersma JF, Nuijens JH, Van Schijndel RJMS, Eeremberg-Balmer AJM, Thijs LG and Aarden LA (1996). Increased plasma levels of Interleukin-6 in Sepsis. Blood 74:1704-1710
13. Calandra T, Gerain J, Heumann D, Baumgartner J-D, Glauser MP and the Swiss-Dutch J5 Immunoglubulin Study Group (1991). High circulating levels of Interleukin-6 in patients with septic shock: evolution during sepsis, prognostic value and interplay with other cytokines. Am J Med 91:23-29
14. Baumann H and Gauldie J (1994). The acute phase response. Immunol Today 15:74-80
15. Steel DM and Whitehead AS (1994). The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. Immunol Today 15:81-88
16. Kew RR, Hyers TM and Webster RO (1990). Human C-reactive protein inhibits neutrophil chemotaxis in vitro: Possible implications for the adult respiratory distress syndrome. J Lab Clin Med 115:339-345
17. Corti A, Fassina G, Marcucci F, Barbanti E and Cassani G (1992). Oligomeric tumor necrosis factor α slowly converts into inactive forms at bioactive levels. Biochem J 284:905-910
18. Schindler R, Mancilla J, Endres S, Ghorbani R, Clark SC and Dinarello CA (1990). Correlations and interactions in the production of interleukin-6 (IL-6), IL-1, and tumor necrosis factor (TNF) in human blood mononuclear cells: IL-6 suppresses IL-1 and TNF. Blood 75:40-47
19. Sipe JD, Gonnerman WA, Loose LD, Knapschaefer G, Xie WJ and Franzblau C (1989). Direct-binding enzyme-linked immunosorbent assay (ELISA) for serum amyloid A (SAA). J Immunol Methods 125:125-135
20. de Oliveira RM, Sipe JD, de Beer FC, Loose LD, Bartle LM, Cecil D and Franzblau C (1994). Rapid, sensitive enzyme-linked immunonosorbent assays (ELISA) for serum amyloid A (apoSAA) in human plasma and tissue culture fluids. Amyloid Int J Exp Clin Invest 1:23-29
21. van Leeuwen MA, van Rijswijk MH, van der Heijde DMFM, Te Meerman GJ, van Riel PLCM, Hautman PM, van de Putte LBA and Limburg PC (1993). The acute-phase response in relation to radiographic progression in early rheumatoid arthritis: A prospective study during the first three years of disease. Brit J Rheum 32:9-13
22. Beutler B, Milsark IW and Cerami AC (1985). Passive immunization against cachectin/tumor necrosis factor protects mice from lethal effect of endotoxin. Science 229:869-871
23. Michie HR, Manogue MBKR, Spriggs DR, Revhaug A, O'Dwyer S, Dinarello CA, Cerami A, Wolff SM and Wilmore DW (1996). Detection of circulating tumor necrosis factor after endotoxin administration. N Engl J Med 318:-32768
24. Elliott MJ, Maini RN, Feldmann M, Long Fox A, Charles P, Katsikis P, Brennan FM, Walker J, Bijl H, Ghrayeb J and et al (1993). Treatment of rheumatoid arthritis with chimeric monoclonal antibodies to tumor necrosis factor alpha. Arthritis Rheum 36:1681-1690
25. Aderka D, Le J and Vilcek J (1989). IL-6 inhibits lipopolysaccharide-induced tumor necrosis factor production in cultured human monocytes, U937 cells, and in mice. J Immunol 11:3517-3523
26. Baumann H, Ziegler SF, Mosley B, Morella KK, Pajovic S and Gearing DP (1993). Reconstitution of the response to leukemia inhibitory factor, oncostatin M, and ciliary neurotrophic factor in hepatoma cells. J Biol Chem 268:8414-8417